- Home
- BOTJ vs BTAI Comparison
BOTJ vs BTAI Comparison
Compare BOTJ & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOTJ | BTAI |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.4M | 35.6M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BOTJ | BTAI |
|---|---|---|
| Price | $20.00 | $1.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.33 |
| AVG Volume (30 Days) | 4.2K | ★ 1.1M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $4,003,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $261.81 |
| P/E Ratio | $14.35 | ★ N/A |
| Revenue Growth | ★ 2.61 | N/A |
| 52 Week Low | $13.03 | $1.17 |
| 52 Week High | $21.49 | $8.08 |
Technical Indicators
Market Signals| Indicator | BOTJ | BTAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 42.83 |
| Support Level | $20.00 | $1.33 |
| Resistance Level | $21.47 | $2.20 |
| Average True Range (ATR) | 0.41 | 0.15 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 57.79 | 11.84 |
Price Performance
Historical ComparisonAbout BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.